Koers Canopy Growth Corp Toronto S.E.
Aandelen
CGC
CA1380351009
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- CAD | - |
31/05 | Piper Sandler beoordeelt Canopy Growth's Q4 | MT |
30/05 | Transcript : Canopy Growth Corporation, Q4 2024 Earnings Call, May 30, 2024 |
Omzet 2024 | 344 mln. 252 mln. 232 mln. | Omzet 2025 * | 302 mln. 221 mln. 203 mln. | Marktkapitalisatie | 870 mln. 638 mln. 586 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | -657 mln. -482 mln. -443 mln. | Nettowinst (verlies) 2025 * | -126 mln. -92,45 mln. -84,94 mln. | EV/omzet 2024 | 4,23 x |
Nettoschuld 2024 | 394 mln. 289 mln. 265 mln. | Nettoschuld 2025 * | 434 mln. 319 mln. 293 mln. | EV/omzet 2025 * | 4,32 x |
K/w-verhouding 2024 |
-1,33
x | K/w-verhouding 2025 * |
-8,74
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,73% |
Recentste transcriptie over Canopy Growth Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Klein
CEO | Chief Executive Officer | 60 | 01-11-18 |
Judy Hong
DFI | Director of Finance/CFO | 52 | 02-12-19 |
Tyler Burns
IRC | Investor Relations Contact | - | 01-01-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Klein
CEO | Chief Executive Officer | 60 | 01-11-18 |
David Lazzarato
CHM | Chairman | 69 | 31-03-20 |
Theresa Yanofsky
BRD | Director/Board Member | 67 | 31-03-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,12% | 6,02 mld. | |
-22,80% | 4,19 mld. | |
+5,44% | 3,25 mld. | |
-19,45% | 2,87 mld. | |
-10,35% | 2,37 mld. | |
+42,72% | 1,89 mld. | |
-5,87% | 1,58 mld. | |
-18,53% | 1,54 mld. | |
-15,33% | 1,5 mld. |
- Beurs
- Aandelen
- Koers WEED
- Koers CGC